FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
Position in ABBV — AbbVie Inc.
CIK 1009016
Cincinnati, OH
Position in ABBV
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$45,207,035
-$183,417 QoQ
Shares Held
207,858
+4.6% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.39348978629641.ToString("F0")%
Shared 0.ToString("F0")%
None 4.606510213703586.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ holds $685,312,998 across 9 Drug Manufacturers - General names. ABBV ranks #6 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,064,304 | $260,158,469 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
2,605,927 | $158,049,472 | |
| 3 | MRK |
Merck & Co., Inc.
|
659,851 | $79,373,476 | |
| 4 | PFE |
Pfizer Inc
|
2,042,039 | $57,340,455 | |
| 5 | LLY |
ELI LILLY & Co
|
52,225 | $48,034,988 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
207,858 | $45,207,035 | |
| 7 | AMGN |
Amgen Inc
|
92,090 | $32,401,865 | |
| 8 | NVS |
Novartis AG
|
29,042 | $4,436,165 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,207,035 | 207,858 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $45,390,452 | 198,654 | Shares | Defined | 2026-01-13 | |
| 2025-09-30 | $45,500,619 | 196,513 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $41,419,245 | 223,140 | Shares | Defined | 2025-07-17 | |
| 2025-03-31 | $47,538,202 | 226,891 | Shares | Defined | 2025-04-16 | |
| 2024-12-31 | $47,841,814 | 269,228 | Shares | Defined | 2025-01-17 | |
| 2024-09-30 | $50,435,403 | 255,395 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $43,812,725 | 255,438 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $46,947,746 | 257,813 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $42,535,855 | 274,478 | Shares | Defined | 2024-01-17 | |
| 2023-09-30 | $40,612,737 | 272,459 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $36,287,369 | 269,334 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $42,965,832 | 269,598 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $44,331,884 | 274,314 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $37,350,508 | 278,299 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $44,383,776 | 289,787 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $50,999,967 | 314,601 | Shares | Defined | 2022-05-03 | |
| 2021-12-31 | $67,850,158 | 501,109 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $58,279,679 | 540,277 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $16,149,872 | 143,376 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $15,496,453 | 143,194 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $15,148,116 | 141,373 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $12,299,737 | 140,424 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $14,213,223 | 144,767 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $10,233,154 | 134,311 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||